Abstract
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disorder of unknown cause that is characterised by fibrofatty replacement, primarily of the right ventricular myocardium, which can lead to life-threatening arrhythmias. It is a disease with a very diverse phenotype. In the present article we describe two sisters, each with a different manifestation of this disorder. The first patient died suddenly at the age of 18 during exercise. Her 17-year-old sister did not have any abnormalities at first cardiac consultation, but a few years later she met several diagnostic criteria for ARVC and an internal cardioverter defibrillator was implanted. Genetic analysis identified a mutation in the plakophilin- 2 (PKP2) gene. Cardiac evaluation of a third sister did not reveal any abnormalities and no mutation in the PKP2 gene was found. Thus, ARVC can vary in its clinical presentation, not only between siblings but also in time. This raises difficulties for the physician for diagnosis, treatment and followup. It is important for the physician involved to consider this disease in patients with palpitations and syncope, especially when there is a family history of ARVC or unexplained sudden death. (Neth Heart J 2007;15:348-53.)
Similar content being viewed by others
References
Frank R, Fontaine G. Electrocardiologie de quatre cas de dysplasie ventriculaire droite arythmogene. Arch Mal Coeur Vaiss 1978;71:963-72.
Thiene G, Nava A, Corrado D, Rossi L, Penelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1998;318:129-33.
Richardson P, Mc Kenna WJ, Bristow M, et al. Report of the 1995 WHO/ISFC task force on the definition and classification of the cardiomyopathies. Circulation 1996;93:841.
Tabib A, Loire R, Chalabreysse L, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003;108:3000-5.
Corrado D, Basso C, Schiavon M, et al. Screening of hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339:364.
Angelini A, Basso C, Nava A, et al. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J 1996;132:203.
McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Diseases of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the international Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
Hamid M, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10:189-94.
McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular dysplasia with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71:1200-6.
Coonar AS, Protonotarios N, Tsatsopoulou A, et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58.
Beffagna G, Occhi G, Nava A, et al. Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005;65:366-73.
Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-4.
van Tintelen JP, Entius MM, Bhuiyan ZA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006; 113:1650-8.
Pilichou K, Nava A, Basso C, et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006;113:1171-9.
Bauce B, Rampazzo A, Basso C, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002;40:341-9.
Bomma C, Rutberg J, Tandri H, et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004;15:300-6.
Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
Corrado D, Leoni L, Link MS, et al. Implantable cardioverterdefibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-91.
Van der Wall EE, Schalij MJ, Van der Laarse A. Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank! Neth Heart J 2006;14:323-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Department of Cardiology, Heart Lung Centre Utrecht, University Medical Centre, Utrecht, the Netherlands
Department of Cardiology, Medical Centre Alkmaar, the Netherlands
Department of Cardiology, Heart Lung Centre Utrecht, University Medical Centre, Utrecht, the Netherlands
Department of Genetics, Academic Medical Centre, Amsterdam, the Netherlands
Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands
Department of Cardiology, Heart Lung Centre Utrecht, University Medical Centre, Utrecht, the Netherlands
L.C. Otterspoor Department of Cardiology, Heart Lung Centre Utrecht, University Medical Centre, PO Box 85500, 3508 GA Utrecht, the Netherlands
Rights and permissions
About this article
Cite this article
Otterspoor, L.C., Reichert, C.L.A., Cramer, M.J.M. et al. Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. NHJL 15, 348–353 (2007). https://doi.org/10.1007/BF03086013
Issue Date:
DOI: https://doi.org/10.1007/BF03086013